Apollo Hospitals Enterprise Ltd
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]
- Market Cap ₹ 1,02,454 Cr.
- Current Price ₹ 7,127
- High / Low ₹ 7,545 / 5,285
- Stock P/E 86.6
- Book Value ₹ 522
- Dividend Yield 0.22 %
- ROCE 15.1 %
- ROE 13.3 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 34.3% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 22.6%
Cons
- Stock is trading at 13.7 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of Nifty500 Multicap Infrastructure 50:30:20 BSE 250 LargeMidCap Index BSE 500 Nifty 500 Multicap 50:25:25 Nifty Healthcare Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,769 | 4,357 | 5,129 | 6,150 | 7,256 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 20,469 | |
3,157 | 3,681 | 4,392 | 5,465 | 6,522 | 7,442 | 8,548 | 9,656 | 9,420 | 12,474 | 14,548 | 16,665 | 17,725 | |
Operating Profit | 612 | 676 | 737 | 684 | 734 | 801 | 1,070 | 1,591 | 1,140 | 2,189 | 2,065 | 2,394 | 2,745 |
OPM % | 16% | 16% | 14% | 11% | 10% | 10% | 11% | 14% | 11% | 15% | 12% | 13% | 13% |
33 | 18 | 47 | 92 | 60 | 24 | 26 | 222 | 103 | 368 | 75 | 105 | 158 | |
Interest | 103 | 119 | 118 | 180 | 257 | 295 | 327 | 533 | 449 | 379 | 381 | 449 | 466 |
Depreciation | 142 | 168 | 212 | 264 | 314 | 359 | 396 | 620 | 573 | 601 | 615 | 687 | 719 |
Profit before tax | 399 | 407 | 455 | 332 | 222 | 171 | 373 | 660 | 221 | 1,578 | 1,144 | 1,362 | 1,719 |
Tax % | 26% | 25% | 29% | 29% | 41% | 65% | 47% | 34% | 38% | 30% | 22% | 33% | |
303 | 315 | 335 | 235 | 131 | 60 | 200 | 432 | 137 | 1,108 | 844 | 935 | 1,224 | |
EPS in Rs | 21.88 | 22.77 | 24.43 | 16.99 | 15.88 | 8.44 | 16.96 | 32.70 | 10.46 | 73.42 | 56.97 | 62.50 | 82.28 |
Dividend Payout % | 25% | 25% | 24% | 35% | 38% | 59% | 35% | 18% | 29% | 16% | 26% | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 15% |
3 Years: | 22% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 34% |
3 Years: | 109% |
TTM: | 70% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 37% |
3 Years: | 9% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 12% |
3 Years: | 14% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 |
Reserves | 2,677 | 2,907 | 3,102 | 3,262 | 3,244 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 | 7,429 |
1,213 | 1,344 | 1,992 | 2,834 | 3,125 | 3,427 | 3,673 | 3,596 | 4,160 | 4,068 | 4,332 | 5,333 | 7,371 | |
854 | 1,029 | 1,296 | 1,195 | 1,665 | 1,917 | 2,159 | 4,354 | 2,629 | 3,570 | 3,886 | 4,474 | 4,676 | |
Total Liabilities | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 19,548 |
2,341 | 2,681 | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 | 10,201 | |
CWIP | 403 | 491 | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 1,042 |
Investments | 527 | 322 | 311 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 | 1,012 |
1,543 | 1,855 | 2,372 | 2,448 | 2,759 | 2,759 | 2,901 | 3,187 | 3,037 | 4,104 | 4,712 | 5,219 | 7,293 | |
Total Assets | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 11,392 | 13,261 | 14,416 | 16,742 | 19,548 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
443 | 373 | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 | |
-733 | -356 | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 | |
373 | -63 | 392 | 330 | 477 | -108 | -215 | -910 | -340 | -792 | -633 | -311 | |
Net Cash Flow | 83 | -46 | 103 | 39 | -52 | 24 | -20 | 94 | 44 | 158 | -113 | 72 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 46 | 44 | 43 | 36 | 38 | 37 | 39 | 33 | 46 | 44 | 49 | 48 |
Inventory Days | 43 | 47 | 50 | 49 | 47 | 51 | 46 | 49 | 16 | 21 | 17 | 17 |
Days Payable | 53 | 55 | 59 | 66 | 51 | 55 | 56 | 60 | 74 | 79 | 82 | 88 |
Cash Conversion Cycle | 36 | 36 | 34 | 19 | 34 | 33 | 29 | 22 | -12 | -14 | -16 | -23 |
Working Capital Days | 17 | 28 | 30 | 27 | 30 | 25 | 16 | 9 | 12 | 13 | 18 | 2 |
ROCE % | 13% | 12% | 12% | 9% | 8% | 7% | 10% | 14% | 8% | 17% | 14% | 15% |
Documents
Announcements
-
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
28 Nov - Schroder Investment Management acquires 5.01% stake in Apollo Hospitals.
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
15 Nov - Intimation of lost share certificates by shareholders.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
12 Nov - Transcript of unaudited financial results presentation.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
7 Nov - Audio recording of Analyst call on financial results.
-
Limited Review Report On Unaudited Financial Results For The Three And Six Months Ended September 30, 2024 With UDIN
6 Nov - Limited Review Report on unaudited financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Concalls
-
Nov 2024TranscriptNotesPPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Apr 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Nov 2020TranscriptPPT
-
Sep 2020TranscriptPPT
-
Jun 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Aug 2019TranscriptPPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Apr 2017Transcript PPT
-
Nov 2016TranscriptPPT
-
Feb 2016TranscriptPPT
-
Nov 2015TranscriptNotesPPT
Hospital segment metrics
Apollo Hospitals has facilities in large urban centers such as Chennai, Hyderabad, Kolkata, Bengaluru, New Delhi, Ahmedabad, Mumbai, Pune, Bhubaneshwar, Madurai and Mysore.
As of Q1FY24, 43 are owned and 6 are managed hospitals, with 9500+ beds, 62% occupancy rate, Rs. 57,760 / day ARPOB and 133,846 In-patients.[1]